AI Stock Analysis - Shattuck Labs (STTK)
Analysis generated October 9, 2025.
Shattuck Labs is a biotechnology company focused on developing novel therapies for the treatment of cancer and autoimmune diseases. The company’s proprietary technology platform, Agonist Redirected Checkpoint (ARC), aims to create effective and safe treatment options by harnessing and enhancing the body's immune response. Despite being a relatively new player in the biotech sector, Shattuck Labs has garnered attention for its innovative approach and potential for significant breakthroughs in critical areas of medicine.
Stock Alerts - Shattuck Labs (STTK)
 |
Shattuck Labs | January 15 Price is down by -6.3% in the last 24h. |
|
Shattuck Labs | January 14 Price is up by 6.2% in the last 24h. |
|
Shattuck Labs | January 12 Price is down by -7.8% in the last 24h. |
|
Shattuck Labs | January 7 Price is up by 6% in the last 24h. |
Download our app to get future alerts delivered in real-time.
Alternative Data for Shattuck Labs
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | 1 | Sign up | Sign up | Sign up |
| Sentiment | 75 | Sign up | Sign up | Sign up |
| Webpage traffic | 3,000 | Sign up | Sign up | Sign up |
| Employee Rating | 94 | Sign up | Sign up | Sign up |
| Google Trends | N/A | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Reddit Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Mentions | 3 | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 645 | Sign up | Sign up | Sign up |
| X Mentions | 10 | Sign up | Sign up | Sign up |
| News Mentions | N/A | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
| Business Outlook | 79 | Sign up | Sign up | Sign up |
| Linkedin Employees | 48 | Sign up | Sign up | Sign up |
About Shattuck Labs
Shattuck Labs, Inc., a clinical-stage biotechnology company, develops therapeutics for the treatment of cancer and autoimmune disease in the United States.
| Price | $4.64 |
| Target Price | Sign up |
| Volume | 482,710 |
| Market Cap | $299M |
| Year Range | $0.73 - $4.8 |
| Dividend Yield | 0% |
| Analyst Rating | 40% buy |
| Industry | Biotechnology |
In the news
 |
Analyst Confidence Upbeat on Shattuck Labs (STTK) Amid SL-325 Progress and Earlier Q3 2025 ResultNovember 28 - Yahoo Entertainment |
 |
Shattuck Labs Reports Third Quarter 2025 Financial Results and Recent Business HighlightsNovember 6 - Yahoo |
 |
Shattuck Labs, Inc. (STTK) Presents at The United European Gastroenterology (UEG) Congress UEG Week 2025 TranscriptOctober 10 - SeekingAlpha |
Shattuck Labs Announces Participation in Upcoming Wedbush Securities Key Opinion Leader (KOL) and Company PanelOctober 2 - GlobeNewswire |
|
 |
Shattuck Labs files to sell 105.27M shares of common stock for holdersSeptember 18 - Thefly.com |
 |
Head to Head Review: Shattuck Labs (NASDAQ:STTK) and Williston (OTCMKTS:WHCA)September 15 - ETF Daily News |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q3 '25 | 1M | 0 | 1M | -10M | -9.1M | -0.140 |
| Q2 '25 | 0 | 930,000 | -930,000 | -12M | -12M | -0.240 |
| Q1 '25 | 14M | 940,000 | -940,000 | -14M | -13M | -0.270 |
| Q4 '24 | 35M | 20M | 14M | -19M | -19M | -0.370 |
| Q3 '24 | 3M | 950,000 | 2M | -17M | -17M | -0.330 |
Insider Transactions View All
| Ashiya Mona filed to buy 1,051,021 shares at $0.9. September 2 '25 |
| Ashiya Mona filed to buy 2,022,277 shares at $0. September 2 '25 |
| Ashiya Mona filed to buy 3,073,298 shares at $0. September 2 '25 |
| Ashiya Mona filed to buy 5,255,106 shares at $0.9. September 2 '25 |
| ORBIMED ADVISORS LLC filed to buy 1,051,021 shares at $0.9. September 2 '25 |
Similar companies
Read more about Shattuck Labs (STTK) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, 4chan mentions, reddit mentions, stocktwits mentions, stocktwits subscribers, x mentions, news mentions, customer reviews, business outlook & linkedin employees.
FAQ - Shattuck Labs
The Market Cap of Shattuck Labs is $299M.
Currently, the price of one share of Shattuck Labs stock is $4.64.
The STTK stock price chart above provides a comprehensive visual representation of Shattuck Labs' stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Shattuck Labs shares. Our platform offers an up-to-date STTK stock price chart, along with technical data analysis and alternative data insights.
As of our latest update, Shattuck Labs (STTK) does not offer dividends to its shareholders. Investors interested in Shattuck Labs should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
Some of the similar stocks of Shattuck Labs are Amgen, Gilead Sciences, Catalyst Pharmaceuticals, Inovio Pharmaceuticals, and Anavex Life Sciences.
